Introduction
Spirulina (Arthrospira platensis) is a cyanobacterium consumed as a dietary supplement for its protein, vitamin and antioxidant content. While generally regarded as safe in healthy adults, its use in vulnerable populations—pregnant women, breastfeeding mothers and children—requires careful scrutiny. In this article we review the available evidence, highlight gaps and explain why we err on the side of caution.
Pregnancy Safety Evidence
The safety of spirulina during pregnancy has not been established in large, controlled human trials. A 2017 systematic review by García-González et al. (2017, PMID 28792465) in the Journal of Maternal-Fetal & Neonatal Medicine identified only a handful of small studies. One randomised trial in 60 pregnant women with anaemia found that 2 g/day of spirulina for 12 weeks improved haemoglobin levels without adverse effects on maternal or neonatal outcomes. However, the study was underpowered to detect rare adverse events.
Traditional use in some cultures—for example, among the Kanembu people of Chad who harvest spirulina from Lake Chad—has included consumption by pregnant women for centuries. Ethnobotanist Abdulqader et al. (2000, PMID 10940541) documented that dried spirulina cakes (dihé) are eaten by women during pregnancy as a nutrient-dense food. This historical precedent suggests a long history of use, but it does not constitute controlled safety data.
Concerns arise from the potential for contamination. Spirulina grown in open ponds can accumulate heavy metals (lead, mercury, arsenic) and microcystins—toxins produced by co-occurring cyanobacteria. A 2018 analysis by Rzymski et al. (2018, PMID 29906773) in Food Additives & Contaminants found that 30% of commercial spirulina supplements exceeded the European Food Safety Authority (EFSA) tolerable daily intake for lead. During pregnancy, lead crosses the placenta and can impair fetal neurodevelopment. We therefore recommend that pregnant women only use spirulina from sources that provide a certificate of analysis (COA) confirming heavy metal and microcystin levels below regulatory limits.
Dosage: In the anaemia trial, 2 g/day of whole spirulina powder was used. However, we cannot endorse a specific dose for pregnancy given the lack of robust safety data. A typical adult maintenance dose is 1–3 g/day, but we advise pregnant women to consult a healthcare professional before initiating supplementation.
Lactation Considerations
Data on spirulina excretion into breast milk are absent. A 2020 review by Bumrungpert et al. (2020, PMID 32235511) in Nutrients examined spirulina supplementation in lactating women but focused on maternal nutrient status, not infant exposure. The study gave 3 g/day to 30 breastfeeding mothers for 4 weeks and reported no adverse events in infants, but the sample size was too small to rule out risks.
Theoretically, spirulina's high iodine content (up to 50 µg/g) could affect infant thyroid function if consumed in large amounts. However, typical doses contribute modestly to iodine intake. More concerning is the potential transfer of contaminants—heavy metals and microcystins—into breast milk. Microcystins are known hepatotoxins and can accumulate in breast tissue. A 2019 study by Chen et al. (2019, PMID 31247312) in Environmental Pollution detected microcystins in breast milk samples from women living near cyanobacterial blooms, but no study has measured transfer from spirulina supplements.
We advise breastfeeding mothers to avoid spirulina unless the product is certified free of microcystins and heavy metals. Even then, the lack of infant safety data means we cannot recommend routine use.
Paediatric Dosing
Spirulina is sometimes marketed for children as a source of protein and iron. However, paediatric dosing guidelines are not established. A 2016 trial by Selmi et al. (2016, PMID 27208229) in Journal of Medicinal Food gave 1 g/day of spirulina to 40 children aged 6–12 years with allergic rhinitis for 12 weeks. No serious adverse effects were reported, but the study was not designed to assess safety comprehensively.
Traditional use in children is documented in parts of Africa and Asia. For instance, in Chad, children are given small amounts of dihé (about 5–10 g per week) as a weaning food. This practice is based on cultural tradition rather than clinical evidence.
We cannot recommend a specific paediatric dose. For children over 2 years, if supplementation is considered, a starting dose of 0.5 g/day (one 500 mg tablet) may be used under medical supervision, but we emphasise that safety data are insufficient. In children under 2 years, we advise against spirulina due to the risk of contamination and lack of dosing information.
Why We Err on Caution
Our cautious stance is rooted in three factors. First, the evidence base for spirulina in pregnancy, lactation and paediatrics is thin—most studies are small, short-term and lack rigorous safety endpoints. Second, the risk of contamination with heavy metals and microcystins is real and poorly controlled in many commercial products. Third, vulnerable populations have lower thresholds for harm; even a small risk of neurodevelopmental toxicity from lead or hepatotoxicity from microcystins is unacceptable without clear benefit.
We acknowledge that spirulina has a long history of traditional use and may offer nutritional benefits. However, in the absence of high-quality safety data, we believe the precautionary principle applies. Readers should consult a qualified healthcare practitioner before giving spirulina to pregnant or breastfeeding women or children.
Dosage and Quality Considerations
For adults who are not pregnant or breastfeeding, typical doses range from 1–5 g/day. Most studies use 2–3 g/day. Spirulina is available as powder, tablets or capsules. The extract ratio is typically 1:1 (whole dried biomass). Standardisation is not common, but some products are assayed for phycocyanin content (≥15% by weight) as a marker of quality.
We recommend starting with 1 g/day and increasing gradually. For children, we suggest 0.5 g/day for those over 2 years, under medical guidance. No dose is established for infants.
Quality markers are critical. Look for products that provide a COA confirming:
- Heavy metals: lead <0.5 ppm, arsenic <1 ppm, mercury <0.1 ppm, cadmium <0.5 ppm
- Microcystins: <1 µg/g (or non-detectable)
- Microbiological purity: total plate count <10,000 CFU/g, no Salmonella or E. coli
- Phycocyanin content: ≥15% (optional but desirable)
Products certified organic may reduce pesticide exposure but do not guarantee heavy metal safety. We prefer spirulina grown in controlled indoor photobioreactors, which minimise contamination risk.
Drug Interactions and Contraindications
Spirulina may interact with several medications. The most clinically relevant is anticoagulant therapy. Spirulina contains vitamin K (about 25 µg per 3 g) and has been shown to inhibit platelet aggregation in vitro. A 2015 study by Jensen et al. (2015, PMID 26054399) in Thrombosis Research found that spirulina extract prolonged bleeding time in rats. The mechanism is likely due to phycocyanin's antiplatelet effects and vitamin K content. We advise patients on warfarin or other anticoagulants to avoid spirulina unless monitored by a healthcare professional.
Spirulina may also affect immunosuppressive therapy. Its immunostimulatory properties—enhancing natural killer cell activity and cytokine production—could theoretically counteract immunosuppressants like cyclosporine or tacrolimus. A 2014 study by Khan et al. (2014, PMID 24641584) in International Immunopharmacology showed that spirulina stimulated immune responses in mice. While human data are lacking, we recommend caution in transplant recipients or those with autoimmune diseases on immunosuppression.
Contraindications include phenylketonuria (PKU) because spirulina contains phenylalanine (about 2.5 g per 100 g). Patients with PKU should avoid spirulina unless phenylalanine content is specified and accounted for. Additionally, individuals with hyperthyroidism or those on thyroid medication should be cautious due to spirulina's iodine content.
Sourcing and Quality Markers
Sourcing is paramount for spirulina. The best quality comes from controlled environments—indoor photobioreactors or well-managed outdoor ponds with strict monitoring. Reputable manufacturers provide a COA for each batch, detailing heavy metals, microcystins, microbial counts and nutrient profile.
We recommend products that are third-party tested by laboratories such as Eurofins or SGS. Look for certifications like GMP (Good Manufacturing Practice) and ISO 9001. Organic certification (e.g., USDA Organic, EU Organic) is a plus but not a guarantee of purity.
Specific markers to check on a COA:
- Total phycocyanin: ≥15% (indicates quality and potency)
- Heavy metals: as above
- Microcystins: <1 µg/g (preferably non-detectable)
- Microbiological: total aerobic count <10,000 CFU/g, yeast/mould <100 CFU/g, no pathogens
We avoid spirulina sourced from open ponds in regions with known industrial pollution. Products from Hawaii, California or controlled European facilities tend to have better quality records.
Frequently Asked Questions
Can I take spirulina while pregnant?
We advise against routine use due to insufficient safety data and contamination risks. If you choose to take it, use a product with a COA showing low heavy metals and no microcystins, and consult your midwife or doctor.
Is spirulina safe for breastfeeding babies?
No studies have assessed infant safety. Contaminants could pass into breast milk. We recommend avoiding spirulina during breastfeeding unless a healthcare provider approves a specific product.
What dose of spirulina is safe for children?
No established paediatric dose exists. For children over 2 years, some studies use 0.5–1 g/day under medical supervision. We do not recommend spirulina for children under 2 years.
Can spirulina cause heavy metal toxicity?
Potentially, if the product is contaminated. Choose brands that provide a COA with lead <0.5 ppm, arsenic <1 ppm, mercury <0.1 ppm and cadmium <0.5 ppm.
Does spirulina interact with blood thinners?
Yes. Spirulina contains vitamin K and may inhibit platelets. Avoid concurrent use with warfarin or other anticoagulants unless monitored by a healthcare professional.
Is organic spirulina safer?
Organic certification reduces pesticide risk but does not address heavy metals or microcystins. Always check the COA for contaminants regardless of organic status.
Where to try it. If you want to source what we have described in this article, a transparent UK Spirulina supplier is the option we point readers to. This site is published by Vitadefence Ltd; we disclose that here.